Blog
Discover how Veristat's innovative approach in a challenging Phase I/II clinical study for a rare ...
download
Case Study
We never assume your problem is straightforward, where old solutions can be applied without careful ...
Stay up-to-date with the latest regulatory guidance updates from the FDA in December 2023. From ...
Learn how Veristat’s Full-Service clinical trial team helped tightly coordinate a Gene Therapy’s ...
Fact Sheet
Adaptive design (AD) trials are increasingly popular as they offer the ability to reduce the ...
Discover how Veristat helped a small-sized biotech company obtain FDA approval for their IND and ...
Explore how Veristat's medical writing and project management expertise propelled a biopharma ...
In 2022, the FDA’s Center for Drug Evaluation and Research (CDER) launched the Accelerating Rare ...
Newsletter
As we wrap up 2023 and approach the festive holiday season, we want to sprinkle some joy by sharing ...